Trends in Healthcare Costs for Inflammatory Bowel Disease in South Korea

Affiliations

Editorial

Yoon Suk Jung. Gut Liver. 2020.

. 2020 Jan 15;14(1):3-4.

doi: 10.5009/gnl19374.

¹ Division of Gastroenterology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.

No abstract available

Conflict of interest statement

CONFLICTS OF INTEREST

No potential conflict of interest relevant to this article was reported.

Changes in Direct Healthcare Costs before and after the Diagnosis of Inflammatory Bowel Disease: A Nationwide Population-Based Study.
Lee J, Im JP, Han K, Kim J, Lee HJ, Chun J, Kim JS. Lee J, et al. Gut Liver. 2020 Jan 15;14(1):89-99. doi: 10.5009/gnl19023. Gut Liver. 2020. PMID: 31158951 Free PMC article.

1. Lee SH, Kwon JE, Cho ML. Immunological pathogenesis of inflammatory bowel disease. Intest Res. 2018;16:26–42. doi: 10.5217/ir.2018.16.1.26. - DOI - PMC - PubMed
1. Ng WK, Wong SH, Ng SC. Changing epidemiological trends of inflammatory bowel disease in Asia. Intest Res. 2016;14:111–119. doi: 10.5217/ir.2016.14.2.111. - DOI - PMC - PubMed
1. Jung YS, Han M, Kim WH, Park S, Cheon JH. Incidence and clinical outcomes of inflammatory bowel disease in South Korea, 2011–2014: a nationwide population-based study. Dig Dis Sci. 2017;62:2102–2112. doi: 10.1007/s10620-017-4640-9. - DOI - PubMed
1. Yen HH, Weng MT, Tung CC, et al. Epidemiological trend in inflammatory bowel disease in Taiwan from 2001 to 2015: a nationwide population based study. Intest Res. 2019;17:54–62. doi: 10.5217/ir.2018.00096. - DOI - PMC - PubMed
1. Lee J, Im JP, Han K, et al. Changes in direct healthcare costs before and after the diagnosis of inflammatory bowel disease: a nationwide population-based study. Gut Liver. 2020;14:89–99. doi: 10.5009/gnl19023. - DOI - PMC - PubMed